SOLUBLE FC GAMMA RECEPTOR FOR TREATMENT OF AUTOIMMUNE BULLOUS DISEASES

The invention generally relates to the field of biotechnology and medicine. It provides an agent, a pharmaceutical composition and a kit for treatment of autoimmune bullous diseases (AMDB). More specifically, the invention relates to the use of a soluble Fc gamma receptor for treating AMDB, and a ph...

Full description

Saved in:
Bibliographic Details
Main Authors SONDERMANN, PETER, TER MEER, DOMINIK, LUDWIG, RALF
Format Patent
LanguageEnglish
French
Published 13.12.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention generally relates to the field of biotechnology and medicine. It provides an agent, a pharmaceutical composition and a kit for treatment of autoimmune bullous diseases (AMDB). More specifically, the invention relates to the use of a soluble Fc gamma receptor for treating AMDB, and a pharmaceutical composition and a kit comprising said receptor. It further involves a method of treatment of AMDB. La présente invention concerne de manière générale les domaines de la biotechnologie et de la médecine. Elle concerne un agent, une composition pharmaceutique et un kit pour le traitement de maladies bulleuses auto-immunes (MBAI). Plus particulièrement, l'invention concerne l'utilisation d'un récepteur soluble de Fc gamma pour le traitement de MBAI et une composition pharmaceutique et un kit comprenant ledit récepteur. L'invention concerne en outre un procédé de traitement de MBAI.
Bibliography:Application Number: CA20132927263